Similar articles for PMID: 28149506

Year	Number of Results
1990	1
1992	1
1994	1
1995	1
1997	1
2000	1
2001	1
2002	1
2003	1
2004	3
2005	7
2006	4
2007	1
2009	2
2010	5
2011	2
2012	3
2013	3
2014	12
2015	8
2016	6
2017	1
2019	1
2024	0

1

Treatment of Hypogonadism: Current and Future Therapies.

Thirumalai A, Berkseth KE, Amory JK. Thirumalai A, et al. F1000Res. 2017 Jan 23;6:68. doi: 10.12688/f1000research.10102.1. eCollection 2017. F1000Res. 2017. PMID: 28149506 Free PMC article. Review.

2

Emerging medication for the treatment of male hypogonadism.

Aydogdu A, Swerdloff RS. Aydogdu A, et al. Expert Opin Emerg Drugs. 2016 Sep;21(3):255-66. doi: 10.1080/14728214.2016.1226799. Expert Opin Emerg Drugs. 2016. PMID: 27552127 Review.

3

Transdermal delivery of testosterone.

Hadgraft J, Lane ME. Hadgraft J, et al. Eur J Pharm Biopharm. 2015 May;92:42-8. doi: 10.1016/j.ejpb.2015.02.015. Epub 2015 Feb 20. Eur J Pharm Biopharm. 2015. PMID: 25709060 Review.

4

[Risks and benefits: new concepts of treatment of late-onset hypogonadism].

Shang XJ, Huang YF. Shang XJ, et al. Zhonghua Nan Ke Xue. 2014 Jun;20(6):483-9. Zhonghua Nan Ke Xue. 2014. PMID: 25029850 Review. Chinese.

5

Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.

Yarrow JF, McCoy SC, Borst SE. Yarrow JF, et al. Steroids. 2010 Jun;75(6):377-89. doi: 10.1016/j.steroids.2010.01.019. Epub 2010 Feb 4. Steroids. 2010. PMID: 20138077 Review.

6

[Treatment of erectile disorders with androgens: When? How?].

Tostain J, Legon C, Ludot T, Castro R, Li GR. Tostain J, et al. Prog Urol. 1997 Apr;7(2):314-9. Prog Urol. 1997. PMID: 9264778 Review. French.

7

Hormonal therapy of male hypogonadism.

Matsumoto AM. Matsumoto AM. Endocrinol Metab Clin North Am. 1994 Dec;23(4):857-75. Endocrinol Metab Clin North Am. 1994. PMID: 7705324 Review.

8

Emerging medication for the treatment of male hypogonadism.

Corona G, Rastrelli G, Vignozzi L, Maggi M. Corona G, et al. Expert Opin Emerg Drugs. 2012 Jun;17(2):239-59. doi: 10.1517/14728214.2012.683411. Epub 2012 May 21. Expert Opin Emerg Drugs. 2012. PMID: 22612692 Review.

9

Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.

Ramasamy R, Scovell JM, Kovac JR, Lipshultz LI. Ramasamy R, et al. J Urol. 2014 Sep;192(3):875-9. doi: 10.1016/j.juro.2014.03.089. Epub 2014 Mar 21. J Urol. 2014. PMID: 24657837

10

Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effects.

Karavolos S, Reynolds M, Panagiotopoulou N, McEleny K, Scally M, Quinton R. Karavolos S, et al. Clin Endocrinol (Oxf). 2015 May;82(5):624-32. doi: 10.1111/cen.12641. Epub 2014 Dec 17. Clin Endocrinol (Oxf). 2015. PMID: 25333666 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year